Stocks Mostly Higher as FDA Approves Gene Therapy; Lululemon and Coinbase Also Rise
- Stock market indexes post modest gains, close near highs for the day
- FDA approves first CRISPR gene-editing treatment, but CRSP stock sinks 8%
- Coinbase jumps nearly 8% as bitcoin price rises
- Lululemon hits all-time high after beating Q3 earnings views
- Booking Holdings breaks out above consolidation, hits new buy point